What were IOL Chemicals & Pharmaceuticals Ltd's latest quarterly results?
IOL Chemicals & Pharmaceuticals Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: +71.0% (stable)
- Revenue Growth YoY: +17.2%
- Operating Margin: 15.0% (expanding)
IOL Chemicals & Pharmaceuticals Ltd: Why Is It Outperforming Nifty 500?
ActiveRS +62.5%Average5w Streak
In , IOL Chemicals & Pharmaceuticals Ltd (Pharma - API & CRAMS) is outperforming Nifty 500 with +62.5% relative strength. Fundamentals: Average. On a 5-week streak.
IOL Chemicals & Pharmaceuticals Ltd Key Facts
- PE Ratio
- 26.9x
- Market Cap
- ₹3,923 Cr
- PAT Growth YoY
- +71%
- Revenue Growth YoY
- +17%
- OPM
- 15.0%
- RS vs Nifty 500
- +62.5%
PE: Mid ExpansionRiding Wave
What's Happening
👔Promoter buying — stake up 4.4% this quarter
🌐FII stake increased 0.6% this quarter
💰Trading 18% above estimated fair value
Key Numbers
PAT Growth YoY
+71%
Stable
Revenue YoY
+17%
Stable
Operating Margin
15.0%
+300 bps YoY
PE Ratio
26.9
Current Price
₹134
Dividend Yield
0.75%
Fundamental Score
56/100
Average
3Y PAT CAGR
0%
Market Cap
3.9K Cr
Valuation
Overvalued12-Week Performance
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
12 weeks agoThis week
How Fast Is IOL Chemicals & Pharmaceuticals Ltd Growing?
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +17% | +2% | Stable |
| PAT (Net Profit) | +71% | 0% | Stable |
| OPM | 15.0% | +300 bps | Expanding |
Other Top Pharma - API & CRAMS Stocks Beating Nifty 500
Frequently Asked Questions: IOL Chemicals & Pharmaceuticals Ltd
Based on publicly available financial data. This is educational research, not investment advice.
Is IOL Chemicals & Pharmaceuticals Ltd's profit growing or declining?
IOL Chemicals & Pharmaceuticals Ltd's profit is growing with an stable trend.
- PAT Growth YoY: +71.0% (latest quarter)
- PAT Growth QoQ: +152.4% (sequential)
- 3-Year PAT CAGR: -0.2%
- Trend: Stable — consistent growth pattern
What is IOL Chemicals & Pharmaceuticals Ltd's revenue growth trend?
IOL Chemicals & Pharmaceuticals Ltd's revenue growth trend is stable.
- Revenue Growth YoY: +17.2%
- Revenue Growth QoQ: +6.7% (sequential)
- 3-Year Revenue CAGR: +1.5%
How is IOL Chemicals & Pharmaceuticals Ltd's operating margin trending?
IOL Chemicals & Pharmaceuticals Ltd's operating margin is expanding.
- Current OPM: 15.0%
- OPM Change YoY: +3.0% basis points
- OPM Change QoQ: +5.0% basis points
What is IOL Chemicals & Pharmaceuticals Ltd's 3-year profit and revenue CAGR?
IOL Chemicals & Pharmaceuticals Ltd's long-term compounding rates
- 3-Year Profit CAGR: -0.2%
- 3-Year Revenue CAGR: +1.5%
Is IOL Chemicals & Pharmaceuticals Ltd's growth accelerating or decelerating?
IOL Chemicals & Pharmaceuticals Ltd's earnings growth is stable with mixed signals on a sequential basis.
- YoY Acceleration: +71.0% bps
- Sequential Acceleration: +80.0% bps
What is IOL Chemicals & Pharmaceuticals Ltd's trailing twelve month (TTM) performance?
IOL Chemicals & Pharmaceuticals Ltd's trailing twelve month (TTM) performance
- TTM PAT: ₹138 Cr
- TTM PAT Growth: +36.6% YoY
- TTM Revenue: ₹2,000 Cr
- TTM Revenue Growth: +11.5% YoY
- TTM Operating Margin: 11.6%
Is IOL Chemicals & Pharmaceuticals Ltd overvalued or undervalued?
IOL Chemicals & Pharmaceuticals Ltd appears overvalued based on our fair value analysis.
- Valuation Signal: Overvalued
- Current PE: 26.9x
- Price-to-Book: 2.2x
What is IOL Chemicals & Pharmaceuticals Ltd's current PE ratio?
IOL Chemicals & Pharmaceuticals Ltd's current PE ratio is 26.9x.
- Current PE: 26.9x
- Market Cap: 3.9K Cr
- Dividend Yield: 0.75%
How does IOL Chemicals & Pharmaceuticals Ltd's valuation compare to its history?
IOL Chemicals & Pharmaceuticals Ltd's current PE is 26.9x.
- Current PE: 26.9x
- Valuation Assessment: Overvalued
What is IOL Chemicals & Pharmaceuticals Ltd's price-to-book ratio?
IOL Chemicals & Pharmaceuticals Ltd's price-to-book ratio is 2.2x.
- Price-to-Book (P/B): 2.2x
- Book Value per Share: ₹61
- Current Price: ₹134
Is IOL Chemicals & Pharmaceuticals Ltd a fundamentally strong company?
IOL Chemicals & Pharmaceuticals Ltd is rated Average with a fundamental score of 55.96/100. This score is calculated from objective financial metrics
- Revenue Growth YoY: +17.2% (10% weight)
- PAT Growth YoY: +71.0% (10% weight)
- PAT Growth QoQ: +152.4% (10% weight)
- Margins expanding (10% weight)
Is IOL Chemicals & Pharmaceuticals Ltd debt free?
IOL Chemicals & Pharmaceuticals Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹135 Cr
What is IOL Chemicals & Pharmaceuticals Ltd's return on equity (ROE) and ROCE?
IOL Chemicals & Pharmaceuticals Ltd's return ratios over recent years
- FY2024: ROCE 12.0%
- FY2025: ROCE 9.0%
- FY2026: ROCE 11.0%
Is IOL Chemicals & Pharmaceuticals Ltd's cash flow positive?
IOL Chemicals & Pharmaceuticals Ltd's operating cash flow is positive (FY2026).
- Cash from Operations (CFO): ₹214 Cr
- Free Cash Flow (FCF): ₹16 Cr
- CFO/PAT Ratio: 155% (strong cash conversion)
What is IOL Chemicals & Pharmaceuticals Ltd's dividend yield?
IOL Chemicals & Pharmaceuticals Ltd's current dividend yield is 0.75%.
- Dividend Yield: 0.75%
- Current Price: ₹134
Who holds IOL Chemicals & Pharmaceuticals Ltd shares — promoters, FII, DII?
IOL Chemicals & Pharmaceuticals Ltd's shareholding pattern (Mar 2026)
- Promoters: 57.5%
- FII (Foreign): 1.7%
- DII (Domestic): 0.0%
- Public: 40.8%
Is promoter holding increasing or decreasing in IOL Chemicals & Pharmaceuticals Ltd?
IOL Chemicals & Pharmaceuticals Ltd's promoter holding has increased recently.
- Current Promoter Holding: 57.5% (Mar 2026)
- Previous Quarter: 52.6% (Dec 2025)
- Change: +4.86% (increasing — positive signal)
How long has IOL Chemicals & Pharmaceuticals Ltd been outperforming Nifty 500?
IOL Chemicals & Pharmaceuticals Ltd has been outperforming Nifty 500 for 5 consecutive weeks, indicating building momentum.
Is IOL Chemicals & Pharmaceuticals Ltd a new momentum entry or an established outperformer?
IOL Chemicals & Pharmaceuticals Ltd is an established outperformer with 5 weeks of consecutive Nifty 500 outperformance.
Is IOL Chemicals & Pharmaceuticals Ltd worth studying for long term investment?
Based on quantitative research signals, here is why IOL Chemicals & Pharmaceuticals Ltd may be worth studying
- Earnings growing at +71.0% YoY
- Operating margins are expanding — OPM at 15.0%
- Cash flow is positive — CFO ₹214 Cr
What is the investment thesis for IOL Chemicals & Pharmaceuticals Ltd?
IOL Chemicals & Pharmaceuticals Ltd investment thesis summary:
Research Signals (Bull Case)
- Revenue growing at +17.2% YoY
- Margins expanding
Risk Factors (Bear Case)
- Appears overvalued
What is the future outlook for IOL Chemicals & Pharmaceuticals Ltd?
IOL Chemicals & Pharmaceuticals Ltd's forward outlook based on current data signals
- Earnings Trend: stable
- Revenue Trend: stable
- Margin Trend: expanding
- Valuation: Overvalued
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.